HomeBREAKING NEWS Bharat Biotech’s Covaxin Shows 77.8% Efficacy in Phase 3 Trial Data June 22, 2021 Share Facebook Twitter Pinterest WhatsApp Covaxin’s Phase 3 trial data which has shown 77.8% efficacy was approved by the Subject Expert Committee (SEC) under DCGI on Tuesday. Previous articleDefence Min Rajnath Singh to Visit CSL on June 25 to Review Progress of Indigenous Aircraft CarrierNext articleMan Threatens to Immolate Self After Accusing Police of Not Investigating Daughter’s Rape Case Similar Articles Lakhimpur Kheri: Viral Video Shows Farmers Being Run Over by SUV, Oppn Questions Union Minister’s Claims BREAKING NEWS - October 5, 2021 The 29-second clip, which also shows another vehicle following the SUV, has raised questions on the version of the incident by Union minister Ajay... Karnataka: 3 Dead After Drinking Contaminated Water, 108 Show Similar Symptoms BREAKING NEWS - October 5, 2021 A total of six people have died in the last five weeks but the authorities have been able link just three of the deaths... Most Popular AMPC reforms: BJP digs out Siddaramaiah’s old letter India UAE Grow Bilateral Trade Amidst Worldwide Geopolitical Shifts Author Amish on why Bollywood doesn’t adapt ancient Sanskritic texts into films